Objective To explore the global research status and trends of continuous renal replacement therapy (CRRT) based on knowledge visualization analysis. Methods Based on the Web of Science Core Collection, studies reporting CRRT research that were published between June 2014 and June 2023 were retrieved and collected after manual review. VOSviewer and CiteSpace softwares were used for bibliometric visualization analysis, including publication trends, geographical distribution characteristics, journal distribution characteristics, author contributions, citations, funding source characteristics, and keyword clustering. Results A total of 2708 papers were analyzed, with an increasing trend in the number of articles and citation frequency from 2015 to 2021. The United States was the most prolific country and France was the most influential country. The University of Pittsburgh in the United States had the highest number of publications among research institutions and showed higher motivation for inter-institutional collaboration. The University of Queensland in the Australia had the highest average citation frequency. Professor Rinaldo Bellomo of Australia was the most productive author and Professor Jeffrey Lipman was the most influential. Jason A. Roberts, Jeffrey Lipman and Claudio Ronco were the three authors who had the highest number of collaborations with other authors. Keyword cluster analysis showed that the prognosis of CRRT for renal disease was the focus of research, with hotspots of research being antibiotics, citrate accumulation, plasma replacement, lactate clearance, acute respiratory distress syndrome, and coronavirus disease 2019. Coupling analysis of the literature showed that exploring the indications for CRRT and optimizing treatment prescription were at the forefront of research. Conclusions The present study of CRRT has generally shown an upward trend in the last decade. The management and efficacy of CRRT remains a hot topic of research. Exploring the indications for CRRT and optimizing treatment prescriptions may be a popular research direction and trend in the future.
ObjectiveTo systematically map the research landscape, hotspots, and evolutionary trends of Chinese-language literature on value-based healthcare (VBHC) in China, and to provide evidence for advancing localized VBHC research and practice. Methods VBHC-related publications published between January 1, 2006 and August 30, 2024 were retrieved from the China National Knowledge Infrastructure, Wanfang Data, and VIP database. CiteSpace was used for visualized bibliometric analyses, including co-authorship, institutional collaboration, keyword co-occurrence, clustering, burst detection, and timeline mapping. Results A total of 237 articles were included. Since 2017, VBHC-related publications in China have increased markedly. Collaboration networks among institutions and authors showed low density, indicating relatively weak and fragmented cooperation. High-frequency keywords included “value co-creation” “public hospitals” and “value orientation”. Burst analysis identified “healthcare costs” “value co-creation” and “medical insurance payment” as major recent research focuses. The timeline map suggested three stages in the evolution of VBHC research: initial exploration, emerging development, and rapid growth of research hotspots. ConclusionsInterest in VBHC research in China continues to grow, yet collaborative research and interdisciplinary integration remain limited. Future efforts should strengthen cross-institutional and cross-disciplinary collaboration, promote the development of shared data platforms, and build VBHC evaluation frameworks tailored to China’s institutional context.
The rapid development of artificial intelligence technology is driving profound changes in medical practice, particularly in the field of medical device application. Based on data from the U.S. clinical trials registry, this study analyzes the global registration landscape of clinical trials involving artificial intelligence-based medical devices, aiming to provide a reference for their clinical research and application. A total of 2 494 clinical trials related to artificial intelligence medical devices have been registered worldwide, with participation from 66 countries or regions. The United States leads with 908 trials, while for other countries or regions, including China, each has fewer than 300 trials. Germany, the United States, and Belgium serve as central hubs for international collaboration. Among the sponsors, 63.96% are universities or hospitals, 22.36% are enterprises, and the remainder includes individuals, government agencies and others. Of all trials, 79.99% are interventional studies, 94.67% place no restrictions on participant gender, and 69.69% exclude children. The targeted diseases are primarily neurological and mental disorders. This study systematically reveals the global distribution characteristics and research trends of artificial intelligence medical device clinical trials, offering valuable data support and practical insights for advancing international collaboration, resource allocation, and policy development in this field.
Objective To analyze the characteristics and changing trends of lung cancer-related projects funded by National Natural Science Foundation of China (NSFC) during 2019–2023, providing a reference for researchers in topic selection and for optimizing scientific research management and resource allocation. Methods Relevant databases, including the NSFC Big Data Knowledge Management Service Platform, were systematically searched to collect information on lung cancer-related funded projects from 2019 to 2023. Quantitative methods were applied to evaluate project categories, funding amounts, and the distribution of host institutions. Project themes were classified according to their titles, keywords, and abstracts, and were subsequently compared with those of projects funded during 2014–2018. Results A total of 1 327 lung cancer-related projects were funded from 2019 to 2023, with total funding of 554.92 million yuan. The Young Scientists Fund and the General Program accounted for 90.3% (1 199/1 327) of the projects and 84.1% (46 675/55 492) of the total funding; the top 10 host institutions comprised approximately 32.0% of all funded projects. Thematic analysis revealed that the core funding directions in the lung cancer field during 2019–2023 focused on molecular mechanisms and signaling pathways. Major research themes included metastasis and recurrence, tumor microenvironment and immunity, and targeted therapy resistance and drug development. Compared with 2014–2018, the proportion of projects focused on tumor microenvironment and immunity, as well as artificial intelligence and medical engineering, increased substantially. Overall, the themes of funded lung cancer projects were dominated by mechanistic studies and demonstrated cross-cutting features intersecting with disease progression, therapeutic resistance, immune regulation, and clinical translation. Conclusion The number of NSFC-funded lung cancer-related projects has continued to grow. Research themes have evolved from pure mechanistic exploration toward immune regulation and translational research, exhibiting characteristics of interdisciplinary integration with emerging technologies and multi-theme cross-fertilization. Researchers are encouraged to align with policy orientations and to emphasize the innovation and translational value of their proposed topics.